James George Robinson, Director at NYMOX PHARMACEUTICAL CORP (NYMX), bought 10,000 shares at $1.52 ($152K) on 2019-06-29, disclosed to the SEC on 2019-07-01.
Open-market purchase of $152k NYMX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.48 | 1,110 | $2K | 1.1% |
| 2 | $1.48 | 800 | $1K | 0.8% |
| 3 | $1.48 | 3,015 | $4K | 2.9% |
| 4 | $1.49 | 1,000 | $1K | 1.0% |
| 5 | $1.52 | 3,155 | $5K | 3.2% |
| 6 | $150.00 | 920 |
| $138K |
| 91.0% |
| Total | $15.16 avg | 10,000 | $152K | 100% |
| Filing → |
| NYMX | BUY | 2022-05-06 | $3.8M | — | Filing → |
| NYMX | BUY | 2021-04-27 | $83K | — | Filing → |
| NYMX | BUY | 2019-07-12 | $12K | — | Filing → |